This 2014 review examines two decades of research on leptin, an adipocyte-derived hormone pivotal in regulating energy balance and metabolism. While leptin therapy has shown remarkable efficacy in rare conditions like congenital leptin deficiency and lipodystrophy, its effectiveness in common obesity and type 2 diabetes (T2D) has been limited due
